Cant be management shake-up. That is straightforward and a...

Cant be management shake-up. That is straightforward and a simple press release would ensue. Not something sudden that turns into this...

As for Novartis puling-out. Nah. The 4th largest Pharma doesn't enter into a long-negotiated deal to withdraw within a month...

Leaves:

Trial outcomes OR Partnership.

Timing of a US driven announcement aligns with MESO off its daily low @ 15:10pm to close up and continue up after-market. Coupled with strong early buying here...

But surely a partnership would be something well organised IN ADVANCE.

So we are left with Trial news...

ARDS makes more sense than CLBP because of the nature of the halt. Given MSB running CLBP, not ARDS, this 'reactive' announcement, points most likely to ARDS...

My confirmation bias pushes me to a positive 60% readout, with ensuing drama that may well be playing out right now @ 55 Collins.

GLTA.